Packaging and storage— Preserve either in single-dose containers, preferably of Type I or Type III glass, protected from light or, where intended for administration with a pressure injector through a suitable transfer connection, in similar glass 500-mL or 1000-mL bottles, protected from light.

Labeling— Label containers of Injection intended for intravascular injection, where packaged in single-dose containers, to direct the user to discard any unused portion remaining in the container or, where packaged in bulk bottles to state, “Bulk Container—only for sterile filling of pressure injectors,” to state that it contains no antimicrobial preservatives, and to direct the user to discard any unused portion remaining in the container after 6 hours. Indicate also in the labeling of bulk bottles that a pressure injector is to be charged with a dose just prior to administration of the Injection. Label containers of Injection intended for other than intravascular injection to show that the contents are not intended for intravascular injection.

USP Reference standards 11—
USP Diatrizoic Acid RS.
USP Diatrizoic Acid Related Compound A RS.
USP Endotoxin RS.

Identification—

Bacterial endotoxins 85— It contains not more than 1.8 USP Endotoxin Units per mL for Injections containing less than 60% of diatrizoate meglumine, and not more than 3.6 USP Endotoxin Units for Injections containing 60% or more of diatrizoate meglumine.

pH 791: between 6.0 and 7.7.

Free aromatic amine— Transfer an accurately measured volume of Injection, equivalent to about 1 g of diatrizoate meglumine and diatrizoate sodium, to a 50-mL volumetric flask. Dilute with water to 5 mL, and add 10 mL of 0.1 N sodium hydroxide. To a second 50-mL volumetric flask transfer 4 mL of water, 10 mL of 0.1 N sodium hydroxide, and 1.0 mL of a Standard solution prepared by dissolving a suitable quantity of USP Diatrizoic Acid Related Compound A RS in 0.1 N sodium hydroxide. Use 0.2 mL of 0.1 N sodium hydroxide for each 5.0 mg of Standard, and dilute with water to obtain a known concentration of 500 µg per mL. Proceed as directed in the test for Free aromatic amine under Diatrizoate Meglumine, beginning with “To a third 50-mL volumetric flask add 5 mL of water”.

Iodine and iodide— Transfer an accurately measured volume of Injection, equivalent to about 2.0 g of the total of diatrizoate meglumine and diatrizoate sodium, to a 50-mL centrifuge tube provided with a stopper. Dilute with water to 24 mL. Add 5 mL of toluene and 5 mL of 2 N sulfuric acid, shake, and centrifuge: the toluene layer shows no red color. Add 1 mL of sodium nitrite solution (1 in 50), shake, and centrifuge: any red color in the toluene layer is not darker than that obtained when a volume of potassium iodide solution (1 in 4000), containing a quantity of iodide corresponding to 0.02% of the weight of diatrizoate meglumine and diatrizoate sodium in the volume of Injection taken is diluted with water to 24 mL and substituted for the solution under test (0.02% of iodide).

Heavy metals 231— In a 50-mL color-comparison tube, mix a volume of Injection, equivalent to 1.0 g of the total of diatrizoate meglumine and diatrizoate sodium, with 5 mL of 1 N sodium hydroxide, dilute with water to 40 mL, and mix. Using this as the Test preparation, proceed as directed in the test for Heavy metals under Diatrizoate Meglumine: the limit is 0.002%.

Other requirements— It meets the requirements under Injections 1.

Assay for diatrizoate meglumine— Pipet 5 mL of Injection into a 10-mL volumetric flask, add water to volume, and mix. Determine the angular rotation (see Optical Rotation 781) of the diluted Injection, using a 100-mm tube. Calculate the content, in mg per mL, of C11H9I3N2O4·C7H17NO5 in the Injection by the formula: in which a is the observed angular rotation, in degrees, corrected for the blank, and the factor 6.01 is the specific rotation, in degrees, of diatrizoate meglumine.

Assay for iodine— Transfer an accurately measured volume of Injection, equivalent to about 4 g of the total of diatrizoate meglumine and diatrizoate sodium, to a 50-mL volumetric flask, dilute with water to volume, and mix. Pipet 5 mL of this solution into a glass-stoppered, 125-mL conical flask, add 30 mL of 1.25 N sodium hydroxide and 500 mg of powdered zinc, connect the flask to a reflux condenser, and reflux the mixture for 1 hour. Cool the flask to room temperature, rinse the condenser with 20 mL of water, disconnect the flask from the condenser, and filter the mixture. Rinse the flask and filter thoroughly, adding the rinsings to the filtrate. Add 5 mL of glacial acetic acid and 1 mL of tetrabromophenolphthalein ethyl ester TS, and titrate with 0.05 N silver nitrate VS until the yellow precipitate just turns green. Each mL of 0.05 N silver nitrate is equivalent to 6.345 mg of iodine.

Topic/Question	Contact	Expert Committee
Monograph	Ian DeVeau, Ph.D. Director, Veterinary Drugs and Radiopharmaceuticals 1-301-816-8178	(RMI05) Radiopharmaceuticals and Medical Imaging Agents 05
Reference Standards	Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org
85	Radhakrishna S Tirumalai, Ph.D. Senior Scientist 1-301-816-8339	(MSA05) Microbiology and Sterility Assurance

USP32–NF27 Page 2110